Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Allan Svendsen, Hoersholm DK

Allan Svendsen, Hoersholm DK

Patent application numberDescriptionPublished
20090203106GALACTANASE VARIANTS - The present invention relates to variants of Glycoside Hydrolase family 53 galactanases, e.g., variants of the galactanases from strains of 08-13-2009
20090217463DETERGENT COMPOSITION COMPRISING LIPASE - This invention relates to compositions comprising certain lipase enzymes and processes for making and using such compositions, including the use of such compositions to clean and/or treat a situs.09-03-2009
20090217464DETERGENT COMPOSITION COMPRISING LIPASE - The invention provides detergent compositions comprising lipolytic enzyme variants having improved in-detergent stability. Lipolytic enzyme variants with improved in-detergent stability are obtained by substituting certain specified amino acid residues in a parent lipolytic enzyme.09-03-2009
20090221033Polypeptides Having Lipase Activity And Polynucleotides Encoding Same - The invention provides polypeptides obtained by introducing mutations in one or more regions identified in a parent lipase. The polypeptides of the present invention have surprisingly been found to have a low specific activity towards short chain fatty acids leading to a reduced odor generation and an increased BR over the lipases known in the art.09-03-2009
20090221034Lipolytic Enzyme Variant With Improved Stability And Polynucleotides Encoding Same - The invention provides lipolytic enzyme variants having improved in-detergent stability and polynucleotides encoding same. Lipolytic enzyme variants with improved in-detergent stability are obtained by substituting certain specified amino acid residues in a parent lipolytic enzyme.09-03-2009
20100003708LIPOLYTIC ENZYME VARIANTS - Lipolytic enzyme variants with increased specificity for short-chain fatty acids can be designed on the basis of a three-dimensional model of a lipolytic enzyme such as 01-07-2010
20100034797Lipase Variants for Pharmaceutical Use - The pharmaceutical use of lipases related to the 02-11-2010
20100047836LIPOLYTIC ENZYME VARIANTS - Molecular dynamics (MD) simulation on the three-dimensional structure of 02-25-2010
20100105092LIPOLYTIC ENZYME VARIANTS - Variants with increased acyl transferase activity can be designed on the basis of a three-dimensional model by making amino acid alterations near the active Ser of lipolytic enzymes such as 04-29-2010
20100183766CGTASE VARIANTS - The inventors have developed a method of modifying the amino acid sequence of a CGTase to obtain variants. The variants may form linear oligosaccharides as an initial product by starch hydrolysis and a reduced amount of cyclodextrin and may be useful for anti-staling in baked products. The method is based on a comparison of three-dimensional (3D) structures of the CGTase with the structure of a maltogenic alpha-amylase where one or both models includes a substrate. The invention also provides novel CGTase variants.07-22-2010
20100196990PROTEASE VARIANTS - The present invention relates to methods for producing variants of a parent RP-II protease and the variants having altered properties as compared to the parent RP-II protease.08-05-2010
20100322915Protease Variants for Pharmaceutical Use - The invention relates to novel variants of a protease derived from 12-23-2010

Patent applications by Allan Svendsen, Hoersholm DK